PlainRecalls
FDA Drug Moderate Class II Terminated

Proctofoam HC (hydrocortisone acetate 1% and pramoxine hydrochloride 1%) topical aerosol, 10 g aerosol containers, Rx Only, Distributed by Meda Pharmaceuticals Inc, Somerset, New Jersey 08873-1120, NDC 0037-6822-10.

Reported: February 2, 2022 Initiated: January 21, 2022 #D-0452-2022

Product Description

Proctofoam HC (hydrocortisone acetate 1% and pramoxine hydrochloride 1%) topical aerosol, 10 g aerosol containers, Rx Only, Distributed by Meda Pharmaceuticals Inc, Somerset, New Jersey 08873-1120, NDC 0037-6822-10.

Reason for Recall

cGMP deficiencies

Details

Recalling Firm
Mylan Pharmaceuticals Inc
Units Affected
233,199/10 g aerosol containers
Distribution
Recalled product was distributed nationwide within the United States.
Location
Morgantown, WV

Frequently Asked Questions

What product was recalled?
Proctofoam HC (hydrocortisone acetate 1% and pramoxine hydrochloride 1%) topical aerosol, 10 g aerosol containers, Rx Only, Distributed by Meda Pharmaceuticals Inc, Somerset, New Jersey 08873-1120, NDC 0037-6822-10.. Recalled by Mylan Pharmaceuticals Inc. Units affected: 233,199/10 g aerosol containers.
Why was this product recalled?
cGMP deficiencies
Which agency issued this recall?
This recall was issued by the FDA Drug on February 2, 2022. Severity: Moderate. Recall number: D-0452-2022.